Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Design Therapeutics, Inc. (DSGN) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Design Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1807120.
Total stock buying since 2021: $62,126,676.
Total stock sales since 2021: $18,057,431.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 562,627 | $2,953,791 | 0 | $0 |
| 2024 | 28,265 | $104,605 | 818,680 | $3,487,077 | 0 | $0 |
| 2023 | 2,268,000 | $5,450,609 | 0 | $0 | 0 | $0 |
| 2022 | 1,840,000 | $15,742,462 | 590,880 | $11,616,563 | 0 | $0 |
| 2021 | 2,050,550 | $40,829,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 562,627 | $2,953,791 | 0 | $0 |
| 2024-12 | 0 | $0 | 3,806 | $23,863 | 0 | $0 |
| 2024-08 | 0 | $0 | 814,874 | $3,463,214 | 0 | $0 |
| 2024-03 | 28,265 | $104,605 | 0 | $0 | 0 | $0 |
| 2023-09 | 21,000 | $49,287 | 0 | $0 | 0 | $0 |
| 2023-08 | 2,247,000 | $5,401,322 | 0 | $0 | 0 | $0 |
| 2022-12 | 1,815,000 | $15,267,788 | 0 | $0 | 0 | $0 |
| 2022-03 | 25,000 | $474,674 | 590,880 | $11,616,563 | 0 | $0 |
| 2021-08 | 40,000 | $618,000 | 0 | $0 | 0 | $0 |
| 2021-03 | 2,010,550 | $40,211,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-13 | William Arsani | Sale | 562,627 | 5.25 | 2,953,791 |
| 2024-12-18 | Prasad Deepa | Sale | 3,806 | 6.27 | 23,863 |
| 2024-08-09 | William Arsani | Sale | 814,874 | 4.25 | 3,463,214 |
| 2024-03-25 | Berger Heather A. | Buy | 1,300 | 3.74 | 4,865 |
| 2024-03-25 | Schmid John P. | Buy | 17,809 | 3.74 | 66,605 |
| 2024-03-22 | Schmid John P. | Buy | 9,156 | 3.62 | 33,135 |
| 2023-09-29 | Lappe Rodney W (Director) | Buy | 21,000 | 2.35 | 49,287 |
| 2023-08-29 | Prasad Deepa (Director) | Buy | 12,000 | 2.31 | 27,672 |
| 2023-08-29 | William Arsani (Director) | Buy | 1,960,000 | 2.44 | 4,782,400 |
| 2023-08-28 | William Arsani (Director) | Buy | 275,000 | 2.15 | 591,250 |
| 2022-12-20 | Sr One Capital Management, Llc (10% Owner) | Buy | 40,000 | 8.14 | 325,439 |
| 2022-12-20 | George Simeon (Director) | Buy | 40,000 | 8.14 | 325,439 |
| 2022-12-19 | Sr One Capital Management, Llc (10% Owner) | Buy | 360,000 | 8.63 | 3,108,240 |
| 2022-12-19 | George Simeon (Director) | Buy | 360,000 | 8.63 | 3,108,240 |
| 2022-12-16 | Sr One Capital Management, Llc (10% Owner) | Buy | 500,000 | 8.28 | 4,140,500 |
| 2022-12-16 | George Simeon (Director) | Buy | 500,000 | 8.28 | 4,140,500 |
| 2022-12-09 | Lappe Rodney W (Director) | Buy | 15,000 | 7.96 | 119,430 |
| 2022-03-22 | Xu Stella (Director) | Sale | 1,455 | 18.63 | 27,105 |
| 2022-03-21 | William Arsani (Director) | Buy | 25,000 | 18.99 | 474,674 |
| 2022-03-21 | Xu Stella (Director) | Sale | 24,000 | 19.01 | 456,240 |
| 2022-03-18 | Xu Stella (Director) | Sale | 565,425 | 19.69 | 11,133,218 |
| 2021-08-31 | William Arsani (Director) | Buy | 40,000 | 15.45 | 618,000 |
| 2021-03-30 | Sr One Capital Management, Llc (10% Owner) | Buy | 250,000 | 20.00 | 5,000,000 |
| 2021-03-30 | Thacker Justin (Vice President, Finance) | Buy | 17,500 | 20.00 | 350,000 |
| 2021-03-30 | Jeffries Sean (Chief Operating Officer) | Buy | 3,050 | 20.00 | 61,000 |
| 2021-03-30 | William Arsani (Director) | Buy | 700,000 | 20.00 | 14,000,000 |
| 2021-03-30 | Cormorant Private Healthcare Fund Iii Lp | Buy | 750,000 | 20.00 | 15,000,000 |
| 2021-03-30 | Xu Stella (Director) | Buy | 10,000 | 20.00 | 200,000 |
| 2021-03-30 | George Simeon (Director) | Buy | 250,000 | 20.00 | 5,000,000 |
| 2021-03-30 | Shah Pratik (Executive Chairperson) | Buy | 25,000 | 20.00 | 500,000 |
| 2021-03-30 | Lappe Rodney W (Director) | Buy | 5,000 | 20.00 | 100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of DSGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Design Therapeutics, Inc. (symbol DSGN, CIK number 1807120) see the Securities and Exchange Commission (SEC) website.